Letter to the Medicines and Healthcare products Regulatory Agency
Sex Matters wrote to the chief executive of the MHRA, Lawrence Tallon, to raise concerns about whether parents and children could meaningfully consent or assent to medical treatment based on hoped-for outcomes that cannot be achieved within the framework of UK law.
Letter to the Medicines and Healthcare products Regulatory Agency
Sex Matters wrote to the chief executive of the MHRA, Lawrence Tallon, to raise concerns about whether parents and children could meaningfully consent or assent to medical treatment based on hoped-for outcomes that cannot be achieved within the framework of UK law.